In Lv-KLK8 treated pancreatic cancer cells, we found that Deguelin and Rapamycin reversed the anti-apoptotic effect of KLK8 overexpression (Figures 7A, B, 8A). The gene discussed is KLK8; the disease is familial pancreatic carcinoma.